VIBI could pull a ENCZ type move--> At Vilacto Bio, we have always known that LACTOACTIVE® – our pharma-grade colostrum compound, weaponized via nanotechnology – had a bright future in immunotherapy and vaccine development. Now, building on our success using LACTOACTIVE® to treat skin diseases, we are taking the next step with LACTOACTIVE iTHER®.
All my posts are based on my opinion. Do not buy, sell, trade any stock based on my posts. Do your own due diligence before making any transaction.